West Pharmaceutical Services, Inc.
WST
$351.96
-$0.18-0.05%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.24% | 4.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.24% | 4.96% | |||
| Cost of Revenue | -0.98% | 9.46% | |||
| Gross Profit | 11.07% | -2.47% | |||
| SG&A Expenses | 12.56% | -7.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 168.18% | -650.00% | |||
| Total Operating Expenses | 2.22% | 4.88% | |||
| Operating Income | 6.93% | 5.22% | |||
| Income Before Tax | 1.47% | 10.94% | |||
| Income Tax Expenses | -27.96% | 34.23% | |||
| Earnings from Continuing Operations | 10.95% | 5.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.95% | 5.07% | |||
| EBIT | 6.93% | 5.22% | |||
| EBITDA | 6.00% | 3.30% | |||
| EPS Basic | 12.83% | 5.51% | |||
| Normalized Basic EPS | 8.48% | 4.52% | |||
| EPS Diluted | 11.98% | 5.49% | |||
| Normalized Diluted EPS | 8.33% | 4.51% | |||
| Average Basic Shares Outstanding | -1.67% | -0.41% | |||
| Average Diluted Shares Outstanding | -1.52% | -0.41% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.10% | -0.05% | |||